Cognitive Health: Normal Aging, MCI, Dementia, Cognitive Reserve, and Cognitive Testing

Introduction

Cognitive health is the ability to think, learn, and remember. Cognitive changes are a part of normal aging, but significant decline is not. Differentiating normal aging from mild cognitive impairment (MCI) and dementia is crucial for early intervention. Lifestyle factors significantly influence cognitive trajectory.

Normal Aging vs MCI vs Dementia

Domain	Normal Aging	Mild Cognitive Impairment (MCI)	Dementia
Memory	Slower recall; occasional word-finding difficulty; remembers important events	Noticeable memory loss to others; forgets recent events, appointments; may misplace items frequently	Significant memory loss interfering with daily life; unable to retain new information
Function	Independent in all activities	Independent but may require more time or compensatory strategies	Dependent on others for some or all activities
Cognition	Subjective complaint but objective tests normal	Objective cognitive impairment (1-1.5 SD below norm) but functional independence maintained	Objective impairment in 2+ domains + functional decline
Progression	Stable	10-15% per year progress to dementia	Progressive decline
Mood/Awareness	Insight preserved; may have anxiety about changes	Often aware and distressed by changes	Variable insight; may be unaware

Cognitive Reserve

Concept	Description
Definition	The brain’s ability to cope with pathology and maintain function; resilience against neurodegeneration
Brain reserve	Structural: brain size, synaptic density, neuronal count
Cognitive reserve	Functional: efficient and flexible neural networks; ability to compensate
Mechanism	More efficient use of existing networks, recruitment of alternate networks
Passive reserve	Genetic, early life nutrition, head size
Active reserve	Education, occupation, cognitive stimulation, physical activity

Factors That Build Cognitive Reserve

Factor	Impact	Mechanism
Education	Higher education = slower cognitive decline; each additional year of education reduces dementia risk by 7-11%	Enhances neural connectivity, develops compensatory strategies
Bilingualism	Delays dementia onset by 4-5 years	Enhanced executive control networks
Cognitive activity	Reading, puzzles, games, learning new skills	Maintains synaptic density, enhances connectivity
Occupational complexity	Complex work with high cognitive demands	Similar to education effects
Physical activity	Increases BDNF, neurogenesis, and synaptic plasticity	Direct neuroprotective effects
Social engagement	Maintains cognitive function, reduces dementia risk by 50% in some studies	Stress reduction, cognitive stimulation, vascular benefits

Brain-Healthy Lifestyle

Physical Activity

Type	Recommendation	Cognitive Benefit
Aerobic exercise	150 min/week moderate (brisk walking, swimming, cycling)	Increased hippocampal volume, BDNF, improved executive function
Resistance training	2x/week	Improved executive function, processing speed
Balance training	2-3x/week (tai chi, yoga)	Fall prevention, may benefit cognition
Combined	Aerobic + resistance	Best outcomes

Diet

Diet Pattern	Key Components	Cognitive Benefit
Mediterranean	High: olive oil, fish, vegetables, fruits, legumes, whole grains; Low: red meat, processed foods	30-50% reduced risk of MCI and dementia
MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay)	Green leafy vegetables, berries (specifically blueberries, strawberries), nuts, fish, poultry, olive oil; avoid red meat, fried foods, sweets	53% risk reduction with high adherence; 35% with moderate adherence
DASH	Low sodium, high potassium/calcium/magnesium, fruits, vegetables, whole grains	Benefits vascular health (indirect cognitive benefit)

Cognitive Training

Type	Examples	Evidence
Formal cognitive training	Computerized programs (BrainHQ, Posit Science), ACTIVE trial	Improved trained domain (reasoning, speed, memory); limited transfer to untrained tasks; reduced risk of cognitive decline
Novel/complex activities	Learning a new language, musical instrument, photography, quilting	Promotes neuroplasticity; limited high-quality evidence
Social engagement	Volunteering, clubs, group activities, senior centers	Moderate protective effect
Mental stimulation	Reading, crossword puzzles, sudoku, board games	Maintains cognitive function

Aspect	Evidence
Social network size	Larger social network = slower cognitive decline
Social integration	50% reduced dementia risk in those with high social integration
Loneliness	Increases dementia risk by 65%
Mechanisms	Cognitive stimulation, stress reduction, increased physical activity, healthy behaviors

Sleep

Aspect	Cognitive Impact
Sleep duration (7-8 hours)	Optimal cognitive function
Sleep <6 hours	Increased amyloid accumulation; impaired memory consolidation
Sleep >9 hours (may be marker of underlying disease)	Associated with increased dementia risk
Sleep quality (fragmented sleep)	Reduced N3 slow wave sleep reduces glymphatic clearance

Cognitive Testing

When to Screen

Indication	Recommendation
Patient concern (subjective cognitive decline)	Screen
Family concern	Screen
Clinical observation (repetition, difficulty with history)	Screen
High-risk populations (>75, vascular risk factors, Parkinson)	Consider
Routine screening (asymptomatic)	Not recommended (USPSTF: insufficient evidence)

Key Cognitive Tests

Test	Time	Domains	Score	Strengths	Weaknesses
MoCA	10-15 min	Visuospatial, executive, naming, memory, attention, language, abstraction, orientation	0-30 (<26 abnormal)	Sensitive for MCI, covers many domains, free	Copyrighted (some restrictions); education effect
MMSE	7-10 min	Orientation, registration, attention, recall, language, construction	0-30 (<24 abnormal)	Widely used, familiar, translated widely	Copyrighted; poor for MCI and frontal/visuospatial
Mini-Cog	2-4 min	Memory (3-word recall) + clock drawing	0-5 (abnormal if 0/3 recall or 1/3 + abnormal clock)	Quick, minimal education effect, free, validated in many settings	Limited domain coverage
SLUMS	7 min	Orientation, memory, attention, executive, visuospatial	0-30 (varies by education)	Free, better than MMSE for MCI	Less widely known
GPCOG	3-4 min	Patient + informant	0-9 (patient); 0-6 (informant)	Validated in primary care	Less sensitive for MCI

Montreal Cognitive Assessment (MoCA) Domains

Section	Points	Domain Assessed	Task
Visuospatial/Executive	5	Executive function	Alternating trail-making, cube copy, clock drawing
Naming	3	Language	Name 3 animals (lion, camel, rhinoceros)
Memory	5 per trial	Short-term memory	Learn 5 words, recall after 5 minutes
Attention	6	Attention/working memory	Digit span, sustained attention (letter A tapping), serial 7s
Language	3	Verbal fluency	Name words starting with F (1 minute); sentence repetition
Abstraction	2	Abstract reasoning	Similarities (train-bicycle, watch-ruler)
Delayed recall	5	Episodic memory	Recall 5 words (recently learned)
Orientation	6	Orientation	Date, month, year, day, place, city

Interpreting Cognitive Test Results

Factor Affecting Performance	Impact	How to Address
Age	Lower scores with advanced age	Use age-adjusted norms
Education	Higher education = higher scores	Use education-adjusted cutoffs
Language/cultural background	May underperform on language-heavy tests	Use culturally validated tests, interpreters
Depression	May mimic cognitive impairment	Screen for depression (PHQ-9, GDS)
Sensory impairment	Poor hearing/vision lowers scores	Ensure glasses/hearing aids; use modified administration
Medications	Sedatives, anticholinergics impair cognition	Review medications
Acute illness	Delirium superimposed on dementia	Differentiate from baseline
Fatigue, anxiety	Underperformance	Administer when patient is well-rested

Longitudinal Monitoring

Frequency	Action
Annual	Screen if concerns, track trajectory
Interval	Repeat cognitive testing at minimum 6-12 months
Change	Reliable change index: MoCA change of 2+ points is clinically significant
Reversible causes	Evaluate for delirium, depression, medication effects, metabolic disturbances, B12, thyroid, sleep apnea

Pharmacologic Prevention

Intervention	Evidence for Prevention
Cholinesterase inhibitors (donepezil, rivastigmine, galantamine)	No evidence for MCI; do NOT use for prevention
Vitamin E	No benefit for prevention (may be harmful at high doses)
NSAIDs	No benefit for prevention
Hormone therapy (estrogen)	No benefit; may increase dementia risk
Ginkgo biloba	No benefit for prevention (GEM study)
Vitamin B6, B12, folate	No benefit unless deficient
Vitamin D	Insufficient evidence; maintain adequate levels
Omega-3 fatty acids	Mixed evidence; possible modest benefit